Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06524492 · ClinicalTrials.gov registry record
Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device
A clinical trial of Hydrocephalus, sponsored by Rhaeos.
- Completed
- Registry status
- 52
- Enrollment target
- 3
- Study locations
NCT06524492 is a study of Hydrocephalus that has completed, run by Rhaeos. The registered enrollment target is 52 participants, below the 130-participant average among 17 other Hydrocephalus trials with a reported enrollment target (60% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT06524492, a study of Hydrocephalus, has completed, sponsored by Rhaeos.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of functional implanted shunts and off-shunt locations will assess the diagnostic non-inferiority of the second-generation device to the first-generation device.
Conditions Studied
Interventions
- DEVICE FlowSense
Study Locations (3)
Illinois
- Rhaeos, Inc. - Chicago
- Northwest Special Recreation Association - Rolling Meadows
Florida
- Tampa Marriott Water Street - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2024-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06524492
The ClinicalTrials.gov registry entry for NCT06524492 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 130-participant average among 17 other Hydrocephalus trials with a reported enrollment target (60% lower). The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which FlowSense is the first listed.
NCT06524492 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT06524492 about?
NCT06524492 is a clinical study titled "Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device". This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of functional implanted shunts and off-shunt locations will assess the diagnostic non-inferiority of the second-generation device to the first-generation devic...
What is the current status of trial NCT06524492?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2024-07-25. Estimated completion is 2024-07-27.
What conditions does trial NCT06524492 study?
This clinical trial studies the following conditions: Hydrocephalus.
What interventions are being tested in trial NCT06524492?
The interventions under investigation include: FlowSense (DEVICE).
Who is sponsoring clinical trial NCT06524492?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06524492 being conducted?
This trial has 3 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NIRS Monitoring in Premature Infants
RECRUITING
-
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
RECRUITING · NA
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
RECRUITING · NA
-
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
RECRUITING · NA
-
CoMind Early Feasibility Study
RECRUITING
-
Flow Detection in Open and Closed Shunt Valve Periods
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.